PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO. Electronic address: andruska.neal@wustl.edu.\', \'Department of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.\', \'Department of Radiation Oncology, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.\', \'Department of Radiation Oncology, Sylvester Cancer Center, University of Miami, FL.\', \'Biostatistics, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.\', \'Department of Radiation Oncology, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA. Electronic address: brian.baumann@wustl.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1558-7673(21)00227-510.1016/j.clgc.2021.11.012
?:hasPublicationType
?:journal
  • Clinical genitourinary cancer
is ?:pmid of
?:pmid
?:pmid
  • 35086762
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.905
?:rankingScore_hIndex
  • 38
?:title
  • Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all